enVVeno Medical (NASDAQ:NVNO) Trading Down 1.8%

Shares of enVVeno Medical Corporation (NASDAQ:NVNO) were down 1.8% during trading on Tuesday . The stock traded as low as $4.90 and last traded at $4.91. Approximately 45,328 shares traded hands during mid-day trading, a decline of 56% from the average daily volume of 102,538 shares. The stock had previously closed at $5.00.

enVVeno Medical Price Performance

The stock has a market cap of $65.72 million, a price-to-earnings ratio of -2.97 and a beta of 1.10. The stock’s 50 day simple moving average is $5.18 and its two-hundred day simple moving average is $4.84.

enVVeno Medical (NASDAQ:NVNO) last issued its earnings results on Wednesday, May 8th. The company reported ($0.31) earnings per share for the quarter. As a group, analysts predict that enVVeno Medical Corporation will post -1.4 earnings per share for the current year.

Insider Activity

In related news, CTO Hamed Alavi sold 8,334 shares of the business’s stock in a transaction on Wednesday, March 13th. The stock was sold at an average price of $6.22, for a total value of $51,837.48. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 17.00% of the company’s stock.

Institutional Trading of enVVeno Medical

Hedge funds have recently modified their holdings of the company. Acadian Asset Management LLC acquired a new stake in shares of enVVeno Medical in the first quarter valued at approximately $37,000. Fermata Advisors LLC acquired a new stake in shares of enVVeno Medical in the 3rd quarter valued at $64,000. Quadrature Capital Ltd bought a new stake in shares of enVVeno Medical during the first quarter worth $103,000. Janney Montgomery Scott LLC acquired a new position in shares of enVVeno Medical during the first quarter valued at $186,000. Finally, RIA Advisory Group LLC bought a new position in enVVeno Medical in the first quarter valued at about $238,000. Institutional investors and hedge funds own 34.71% of the company’s stock.

enVVeno Medical Company Profile

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).